Also categorized in Pre-Clinical:
Modified blood-thinning drug could target neuroblastoma | Cancer Research UK
x hide permanently

PD-L1 checkpoint inhibition and anti-CTLA-4 whole tumor cell vaccination counter adaptive immune resistance: A mouse neuroblastoma model that mimics human disease.

ncbi.nlm.nih.gov

PD-L1 checkpoint inhibition and anti-CTLA-4 whole tumor cell vaccination counter adaptive immune resistance: A mouse neuroblastoma model that mimics human disease.

PLoS Med. 2018 Jan;15(1):e1002497

Authors: Srinivasan P, Wu X, Basu M, Rossi C, Sandler AD

Mentions: PD-1